Additionally, it is essential to consider the involvement of several transcription factors, such as Ezh2, c-Fos, Livin, CDC20, survivin, PI3K/Akt, and AURKA, as downstream target genes of MALAT-1 in the context of targeted therapy for RCC. This evidence concerns the gene BIRC7 and renal cell carcinoma.